It is interesting watching Heb jump up. I really can't understand why. I also can't understand why you are quoting an article from 2009. I thought that Heb has to redo their phase 3 study before any possible approval of Ampligen for CFS. If they do begin the study, wouldn't Heb still be 3 or 4 years from approval? Can you explain why you think this can have a bearing on the recent jump in pps? I don't believe that approval for Alferon in a S.A. country would cause such a jump.
AGREE!! I'm beginning to believe quite a few posting on this board are the equivalent of immature children that are splitting their time here "ranting and raving" and the "OCCUPY MOVEMENT"!!! STOCKROACH